Delivery Order SPE2DB22D2009-SPE2DB25FL7YY

Award Date 2/20/25
Potential Completion Date 2/21/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price delivery order, valued at $1,008.48, is for the supply of 90 mcg Albuterol HFA inhalers. The contract has an ultimate completion date of May 17, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,530.22, is for the delivery of Albuterol HFA 90 MCG inhalers. The contract is a Firm Fixed Price Delivery Order with a completion date of May 17, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,461.04, is a Firm Fixed Price Delivery Order for the supply of 4567342018 - ALBUTEROL HFA 90 MCG INHALER 8.5GM. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,642.38, is a firm fixed-price delivery order for the supply of 4564739400 - Albuterol HFA 90 MCG Inhaler 8.5GM. The contract has a completion date of May 30, 2024 and was awarded on May 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,605.96 delivery order is for the supply of Albuterol HFA 90 MCG inhalers, with an ultimate completion date of November 15, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,193.56 Firm Fixed Price Delivery Order contract is for the supply of 4566873689 ALBUTEROL HFA 90 MCG INHALER 8.5GM. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,425.19, is for the delivery of 4563268448 - Albuterol HFA 90 mcg inhalers. It is a firm fixed-price delivery order with a completion date of January 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,094.60 firm-fixed-price delivery order is for the supply of 4566373808 ALBUTEROL HFA 90 MCG INHALER 8.5GM. The contract has a ceiling value of $1,094.60 and an ultimate completion date of November 8, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,297.94 firm fixed price delivery order is for the supply of 4,567,052,772 units of Albuterol HFA 90 MCG inhalers (6.7 grams each) with a completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) under a Delivery Order valued at $1,171.89. The contract is for the supply of Albuterol HFA 90 MCG Inhaler 8.5GM, a critical medical commodity used in respiratory care. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB25FL7YY
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,668.89, is a Firm Fixed Price Delivery Order for the supply of Albuterol HFA 90 MCG Inhalers. The contract has an ultimate completion date of February 21, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award is part of AmerisourceBergen's extensive portfolio of federal contract awards with the DLA and other agencies, demonstrating the company's critical role in supplying essential medical commodities to the U.S. government.

Generated 5/22/25, 8:34 PM